BioPET: Biomarker Prognostic Enrichment Tool

Prognostic Enrichment is a clinical trial strategy of evaluating an intervention in a patient population with a higher rate of the unwanted event than the broader patient population (R. Temple (2010) <DOI:10.1038/clpt.2010.233>). A higher event rate translates to a lower sample size for the clinical trial, which can have both practical and ethical advantages. This package is a tool to help evaluate biomarkers for prognostic enrichment of clinical trials.

AuthorJeremy Roth [cre, aut], Kathleen F. Kerr [aut], Kehao Zhu [aut]
Date of publication2016-07-04 20:37:10
MaintainerJeremy Roth <jhroth@uw.edu>
LicenseGPL (>= 2)
Version0.2.0

View on CRAN

Questions? Problems? Suggestions? or email at ian@mutexlabs.com.

All documentation is copyright its authors; we didn't write any of that.